Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression
ConclusionOur results suggest that MDR1 is an attractive therapeutic target for chemoresistant OS. Tumor-specific virotherapy is thus a promising strategy for reversing chemoresistance in OS patients via suppression of MDR1 expression.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Adenoviruses | Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Chemotherapy | Children | Drugs & Pharmacology | Multidrug Resistance | Osteosarcoma | Virotherapy